[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Outsourcing in Drug Discovery Market Size, Status and Forecast 2020-2026

July 2020 | 94 pages | ID: C83FB8418B9EEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Outsourcing in Drug Discovery market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Outsourcing in Drug Discovery industry.

Based on our recent survey, we have several different scenarios about the Outsourcing in Drug Discovery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Outsourcing in Drug Discovery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Outsourcing in Drug Discovery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Outsourcing in Drug Discovery market in terms of revenue.

Players, stakeholders, and other participants in the global Outsourcing in Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Outsourcing in Drug Discovery market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Outsourcing in Drug Discovery market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Outsourcing in Drug Discovery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Outsourcing in Drug Discovery market.

The following players are covered in this report:
  • Charles River Laboratories
  • ICON
  • Parexel
  • PPD
  • PRA Health Sciences
  • Wuxi AppTec
  • Recipharm
Outsourcing in Drug Discovery Breakdown Data by Type
  • Small Molecules
  • Large Molecules
Outsourcing in Drug Discovery Breakdown Data by Application
  • Hospitals and Clinics
  • Medical Laboratories
  • Others
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Outsourcing in Drug Discovery Revenue
1.4 Market Analysis by Type
  1.4.1 Global Outsourcing in Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Small Molecules
  1.4.3 Large Molecules
1.5 Market by Application
  1.5.1 Global Outsourcing in Drug Discovery Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Medical Laboratories
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Outsourcing in Drug Discovery Industry Impact
  1.6.1 How the Covid-19 is Affecting the Outsourcing in Drug Discovery Industry
    1.6.1.1 Outsourcing in Drug Discovery Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Outsourcing in Drug Discovery Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Outsourcing in Drug Discovery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Outsourcing in Drug Discovery Market Perspective (2015-2026)
2.2 Outsourcing in Drug Discovery Growth Trends by Regions
  2.2.1 Outsourcing in Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Outsourcing in Drug Discovery Historic Market Share by Regions (2015-2020)
  2.2.3 Outsourcing in Drug Discovery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Outsourcing in Drug Discovery Market Growth Strategy
  2.3.6 Primary Interviews with Key Outsourcing in Drug Discovery Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Outsourcing in Drug Discovery Players by Market Size
  3.1.1 Global Top Outsourcing in Drug Discovery Players by Revenue (2015-2020)
  3.1.2 Global Outsourcing in Drug Discovery Revenue Market Share by Players (2015-2020)
  3.1.3 Global Outsourcing in Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Outsourcing in Drug Discovery Market Concentration Ratio
  3.2.1 Global Outsourcing in Drug Discovery Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Outsourcing in Drug Discovery Revenue in 2019
3.3 Outsourcing in Drug Discovery Key Players Head office and Area Served
3.4 Key Players Outsourcing in Drug Discovery Product Solution and Service
3.5 Date of Enter into Outsourcing in Drug Discovery Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Outsourcing in Drug Discovery Historic Market Size by Type (2015-2020)
4.2 Global Outsourcing in Drug Discovery Forecasted Market Size by Type (2021-2026)

5 OUTSOURCING IN DRUG DISCOVERY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Outsourcing in Drug Discovery Market Size by Application (2015-2020)
5.2 Global Outsourcing in Drug Discovery Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Outsourcing in Drug Discovery Market Size (2015-2020)
6.2 Outsourcing in Drug Discovery Key Players in North America (2019-2020)
6.3 North America Outsourcing in Drug Discovery Market Size by Type (2015-2020)
6.4 North America Outsourcing in Drug Discovery Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Outsourcing in Drug Discovery Market Size (2015-2020)
7.2 Outsourcing in Drug Discovery Key Players in Europe (2019-2020)
7.3 Europe Outsourcing in Drug Discovery Market Size by Type (2015-2020)
7.4 Europe Outsourcing in Drug Discovery Market Size by Application (2015-2020)

8 CHINA

8.1 China Outsourcing in Drug Discovery Market Size (2015-2020)
8.2 Outsourcing in Drug Discovery Key Players in China (2019-2020)
8.3 China Outsourcing in Drug Discovery Market Size by Type (2015-2020)
8.4 China Outsourcing in Drug Discovery Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Outsourcing in Drug Discovery Market Size (2015-2020)
9.2 Outsourcing in Drug Discovery Key Players in Japan (2019-2020)
9.3 Japan Outsourcing in Drug Discovery Market Size by Type (2015-2020)
9.4 Japan Outsourcing in Drug Discovery Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Outsourcing in Drug Discovery Market Size (2015-2020)
10.2 Outsourcing in Drug Discovery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Outsourcing in Drug Discovery Market Size by Type (2015-2020)
10.4 Southeast Asia Outsourcing in Drug Discovery Market Size by Application (2015-2020)

11 INDIA

11.1 India Outsourcing in Drug Discovery Market Size (2015-2020)
11.2 Outsourcing in Drug Discovery Key Players in India (2019-2020)
11.3 India Outsourcing in Drug Discovery Market Size by Type (2015-2020)
11.4 India Outsourcing in Drug Discovery Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Outsourcing in Drug Discovery Market Size (2015-2020)
12.2 Outsourcing in Drug Discovery Key Players in Central & South America (2019-2020)
12.3 Central & South America Outsourcing in Drug Discovery Market Size by Type (2015-2020)
12.4 Central & South America Outsourcing in Drug Discovery Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Charles River Laboratories
  13.1.1 Charles River Laboratories Company Details
  13.1.2 Charles River Laboratories Business Overview and Its Total Revenue
  13.1.3 Charles River Laboratories Outsourcing in Drug Discovery Introduction
  13.1.4 Charles River Laboratories Revenue in Outsourcing in Drug Discovery Business (2015-2020))
  13.1.5 Charles River Laboratories Recent Development
13.2 ICON
  13.2.1 ICON Company Details
  13.2.2 ICON Business Overview and Its Total Revenue
  13.2.3 ICON Outsourcing in Drug Discovery Introduction
  13.2.4 ICON Revenue in Outsourcing in Drug Discovery Business (2015-2020)
  13.2.5 ICON Recent Development
13.3 Parexel
  13.3.1 Parexel Company Details
  13.3.2 Parexel Business Overview and Its Total Revenue
  13.3.3 Parexel Outsourcing in Drug Discovery Introduction
  13.3.4 Parexel Revenue in Outsourcing in Drug Discovery Business (2015-2020)
  13.3.5 Parexel Recent Development
13.4 PPD
  13.4.1 PPD Company Details
  13.4.2 PPD Business Overview and Its Total Revenue
  13.4.3 PPD Outsourcing in Drug Discovery Introduction
  13.4.4 PPD Revenue in Outsourcing in Drug Discovery Business (2015-2020)
  13.4.5 PPD Recent Development
13.5 PRA Health Sciences
  13.5.1 PRA Health Sciences Company Details
  13.5.2 PRA Health Sciences Business Overview and Its Total Revenue
  13.5.3 PRA Health Sciences Outsourcing in Drug Discovery Introduction
  13.5.4 PRA Health Sciences Revenue in Outsourcing in Drug Discovery Business (2015-2020)
  13.5.5 PRA Health Sciences Recent Development
13.6 Wuxi AppTec
  13.6.1 Wuxi AppTec Company Details
  13.6.2 Wuxi AppTec Business Overview and Its Total Revenue
  13.6.3 Wuxi AppTec Outsourcing in Drug Discovery Introduction
  13.6.4 Wuxi AppTec Revenue in Outsourcing in Drug Discovery Business (2015-2020)
  13.6.5 Wuxi AppTec Recent Development
13.7 Recipharm
  13.7.1 Recipharm Company Details
  13.7.2 Recipharm Business Overview and Its Total Revenue
  13.7.3 Recipharm Outsourcing in Drug Discovery Introduction
  13.7.4 Recipharm Revenue in Outsourcing in Drug Discovery Business (2015-2020)
  13.7.5 Recipharm Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Outsourcing in Drug Discovery Key Market Segments
Table 2. Key Players Covered: Ranking by Outsourcing in Drug Discovery Revenue
Table 3. Ranking of Global Top Outsourcing in Drug Discovery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Outsourcing in Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Small Molecules
Table 6. Key Players of Large Molecules
Table 7. COVID-19 Impact Global Market: (Four Outsourcing in Drug Discovery Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Outsourcing in Drug Discovery Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Outsourcing in Drug Discovery Players to Combat Covid-19 Impact
Table 12. Global Outsourcing in Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Outsourcing in Drug Discovery Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Outsourcing in Drug Discovery Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Outsourcing in Drug Discovery Market Share by Regions (2015-2020)
Table 16. Global Outsourcing in Drug Discovery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Outsourcing in Drug Discovery Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Outsourcing in Drug Discovery Market Growth Strategy
Table 22. Main Points Interviewed from Key Outsourcing in Drug Discovery Players
Table 23. Global Outsourcing in Drug Discovery Revenue by Players (2015-2020) (Million US$)
Table 24. Global Outsourcing in Drug Discovery Market Share by Players (2015-2020)
Table 25. Global Top Outsourcing in Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Outsourcing in Drug Discovery as of 2019)
Table 26. Global Outsourcing in Drug Discovery by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Outsourcing in Drug Discovery Product Solution and Service
Table 29. Date of Enter into Outsourcing in Drug Discovery Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 32. Global Outsourcing in Drug Discovery Market Size Share by Type (2015-2020)
Table 33. Global Outsourcing in Drug Discovery Revenue Market Share by Type (2021-2026)
Table 34. Global Outsourcing in Drug Discovery Market Size Share by Application (2015-2020)
Table 35. Global Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 36. Global Outsourcing in Drug Discovery Market Size Share by Application (2021-2026)
Table 37. North America Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 39. North America Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 40. North America Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 41. North America Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 42. North America Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 43. Europe Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 45. Europe Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 47. Europe Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 49. China Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 50. China Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 51. China Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 52. China Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 53. China Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 54. China Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 55. Japan Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 57. Japan Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 59. Japan Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 63. Southeast Asia Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 65. Southeast Asia Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 67. India Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 68. India Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 69. India Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 70. India Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 71. India Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 72. India Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Outsourcing in Drug Discovery Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Outsourcing in Drug Discovery Market Share (2019-2020)
Table 75. Central & South America Outsourcing in Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Outsourcing in Drug Discovery Market Share by Type (2015-2020)
Table 77. Central & South America Outsourcing in Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Outsourcing in Drug Discovery Market Share by Application (2015-2020)
Table 79. Charles River Laboratories Company Details
Table 80. Charles River Laboratories Business Overview
Table 81. Charles River Laboratories Product
Table 82. Charles River Laboratories Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 83. Charles River Laboratories Recent Development
Table 84. ICON Company Details
Table 85. ICON Business Overview
Table 86. ICON Product
Table 87. ICON Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 88. ICON Recent Development
Table 89. Parexel Company Details
Table 90. Parexel Business Overview
Table 91. Parexel Product
Table 92. Parexel Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 93. Parexel Recent Development
Table 94. PPD Company Details
Table 95. PPD Business Overview
Table 96. PPD Product
Table 97. PPD Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 98. PPD Recent Development
Table 99. PRA Health Sciences Company Details
Table 100. PRA Health Sciences Business Overview
Table 101. PRA Health Sciences Product
Table 102. PRA Health Sciences Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 103. PRA Health Sciences Recent Development
Table 104. Wuxi AppTec Company Details
Table 105. Wuxi AppTec Business Overview
Table 106. Wuxi AppTec Product
Table 107. Wuxi AppTec Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 108. Wuxi AppTec Recent Development
Table 109. Recipharm Company Details
Table 110. Recipharm Business Overview
Table 111. Recipharm Product
Table 112. Recipharm Revenue in Outsourcing in Drug Discovery Business (2015-2020) (Million US$)
Table 113. Recipharm Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Outsourcing in Drug Discovery Market Share by Type: 2020 VS 2026
Figure 2. Small Molecules Features
Figure 3. Large Molecules Features
Figure 4. Global Outsourcing in Drug Discovery Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Medical Laboratories Case Studies
Figure 7. Others Case Studies
Figure 8. Outsourcing in Drug Discovery Report Years Considered
Figure 9. Global Outsourcing in Drug Discovery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Outsourcing in Drug Discovery Market Share by Regions: 2020 VS 2026
Figure 11. Global Outsourcing in Drug Discovery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Outsourcing in Drug Discovery Market Share by Players in 2019
Figure 14. Global Top Outsourcing in Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Outsourcing in Drug Discovery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Outsourcing in Drug Discovery Revenue in 2019
Figure 16. North America Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Outsourcing in Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Charles River Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Charles River Laboratories Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 25. ICON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. ICON Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 27. Parexel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Parexel Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 29. PPD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. PPD Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 31. PRA Health Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. PRA Health Sciences Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 33. Wuxi AppTec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Wuxi AppTec Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 35. Recipharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Recipharm Revenue Growth Rate in Outsourcing in Drug Discovery Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed


More Publications